IRadimed
IRMD
#5606
Rank
โ‚ฌ1.04 B
Marketcap
81,97ย โ‚ฌ
Share price
0.96%
Change (1 day)
59.67%
Change (1 year)
Categories

Revenue for IRadimed (IRMD)

Revenue in 2025 (TTM): โ‚ฌ72.04 Million

According to IRadimed's latest financial reports the company's current revenue (TTM ) is โ‚ฌ69.11 Million. In 2024 the company made a revenue of โ‚ฌ70.38 Million an increase over the revenue in the year 2023 that were of โ‚ฌ59.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IRadimed from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ72.04 M2.36%
2024 โ‚ฌ70.38 M18.68%
2023 โ‚ฌ59.3 M19.35%
2022 โ‚ฌ49.69 M34.59%
2021 โ‚ฌ36.92 M43.18%
2020 โ‚ฌ25.78 M-25%
2019 โ‚ฌ34.38 M29.22%
2018 โ‚ฌ26.6 M38.31%
2017 โ‚ฌ19.23 M-37.73%
2016 โ‚ฌ30.89 M6.92%
2015 โ‚ฌ28.89 M124.51%
2014 โ‚ฌ12.87 M56.74%
2013 โ‚ฌ8.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AtriCure
ATRC
โ‚ฌ0.44 B 543.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
โ‚ฌ1.05 B 1,423.05%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚ฌ3.87 B 5,509.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
โ‚ฌ5.05 B 7,208.05%๐Ÿ‡บ๐Ÿ‡ธ USA